Literature DB >> 30833833

Carcinoid Heart Disease: Review of Current Knowledge.

Pradhum Ram, Jorge L Penalver, Kevin Bryan U Lo, Janani Rangaswami, Gregg S Pressman.   

Abstract

Carcinoid heart disease is the collective term for all cardiac manifestations in patients who have carcinoid syndrome. Carcinoid heart disease has a multifactorial pathophysiology, and the right side of the heart is usually involved. Symptoms and signs vary depending upon the affected cardiac components; most typical is right-sided heart failure secondary to diseased tricuspid and pulmonary valves. Despite no single ideal diagnostic test, strong suspicion, coupled with serologic and imaging results, usually enables diagnosis. Advances in imaging, such as speckle-tracking echocardiography and cardiac magnetic resonance, have improved the diagnostic yield. Treatment is challenging, warrants a multidisciplinary approach, and can be medical or surgical depending on the cardiac manifestations. Investigators are exploring the therapeutic use of monoclonal antibodies and new somatostatin analogues. In this review, we cover current knowledge about the pathophysiology, diagnosis, and treatment of carcinoid heart disease.

Entities:  

Keywords:  Biomarkers/blood; carcinoid heart disease/blood/diagnostic imaging/physiopathology/therapy/urine; carcinoid tumor/complications/diagnosis/epidemiology/mortality/pathology/surgery; disease progression; heart valve diseases/complications; malignant carcinoid syndrome/pathology; neuroendocrine tumors/pathology; pulmonary valve insufficiency/etiology; serotonin/metabolism; tricuspid valve insufficiency/etiology

Mesh:

Year:  2019        PMID: 30833833      PMCID: PMC6378997          DOI: 10.14503/THIJ-17-6562

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  89 in total

Review 1.  Atrial fibrillation in carcinoid heart disease: The role of serotonin. A review of the literature.

Authors:  C Langer; C Piper; J Vogt; J Heintze; T Butz; O Lindner; W Burchert; C Kersting; D Horstkotte
Journal:  Clin Res Cardiol       Date:  2006-11-24       Impact factor: 5.460

Review 2.  Carcinoid heart disease.

Authors:  Sanjeev Bhattacharyya; Joseph Davar; Gilles Dreyfus; Martyn E Caplin
Journal:  Circulation       Date:  2007-12-11       Impact factor: 29.690

3.  Magnetic resonance imaging diagnosis of carcinoid heart disease.

Authors:  Gorka Bastarrika; María González Cao; David Cano; Joaquín Barba; José D Sáenz de Buruaga
Journal:  J Comput Assist Tomogr       Date:  2005 Nov-Dec       Impact factor: 1.826

Review 4.  Current status of gastrointestinal carcinoids.

Authors:  Irvin M Modlin; Mark Kidd; Igor Latich; Michelle N Zikusoka; Michael D Shapiro
Journal:  Gastroenterology       Date:  2005-05       Impact factor: 22.682

Review 5.  The optimal use of cardiac imaging in the quantification of carcinoid heart disease.

Authors:  Rebecca Dobson; Daniel J Cuthbertson; Malcolm I Burgess
Journal:  Endocr Relat Cancer       Date:  2013-08-19       Impact factor: 5.678

6.  Failure of balloon dilatation of the pulmonary valve in carcinoid pulmonary stenosis.

Authors:  S C Grant; J H Scarffe; R D Levy; N H Brooks
Journal:  Br Heart J       Date:  1992-06

7.  Double bioprosthetic valve replacement in right-sided carcinoid heart disease.

Authors:  Pieter G Voigt; Jerry Braun; Onno Y Teng; Dave R Koolbergen; Eduard Holman; Jeroen J Bax; Vincent T H B M Smit; Robert A E Dion
Journal:  Ann Thorac Surg       Date:  2005-06       Impact factor: 4.330

8.  A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies.

Authors:  Tanios S Bekaii-Saab; Julie M Roda; Kristan D Guenterberg; Bhuvanaswari Ramaswamy; Donn C Young; Amy K Ferketich; Tammy A Lamb; Michael R Grever; Charles L Shapiro; William E Carson
Journal:  Mol Cancer Ther       Date:  2009-11-03       Impact factor: 6.261

9.  Factors associated with progression of carcinoid heart disease.

Authors:  Jacob E Møller; Heidi M Connolly; Joseph Rubin; James B Seward; Karen Modesto; Patricia A Pellikka
Journal:  N Engl J Med       Date:  2003-03-13       Impact factor: 91.245

10.  Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina.

Authors:  E P McFadden; J G Clarke; G J Davies; J C Kaski; A W Haider; A Maseri
Journal:  N Engl J Med       Date:  1991-03-07       Impact factor: 91.245

View more
  6 in total

1.  Pheochromocytoma: Another Neuroendocrine Tumor that Substantially Affects the Heart.

Authors:  Run Yu
Journal:  Tex Heart Inst J       Date:  2019-06-01

Review 2.  How to Manage Small Intestine (Jejunal and Ileal) Neuroendocrine Neoplasms Presenting with Liver Metastases?

Authors:  Bruno Niederle; Andreas Selberherr; Martin B Niederle
Journal:  Curr Oncol Rep       Date:  2021-05-20       Impact factor: 5.075

Review 3.  Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management.

Authors:  Francesca Spada; Roberta E Rossi; Elda Kara; Alice Laffi; Sara Massironi; Manila Rubino; Franco Grimaldi; Sherrie Bhoori; Nicola Fazio
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-04

4.  First Case of Regression of Carcinoid Heart Disease on Serial Transthoracic Echocardiograms following Octreotide Monotherapy in a Patient with Metastatic Pancreatic Neuroendocrine Tumor.

Authors:  Ermin Nath; Michael B Sawyer; Jonathan Choy
Journal:  Case Rep Oncol       Date:  2020-12-10

5.  A forgotten diagnosis in right heart failure: A case report and literature review.

Authors:  Azin Alizadehasl; Bahar Galeshi; Mehdi Peighambari; Hamidreza Pouraliakbar; Maryam Moradian; Arash Hashemi
Journal:  Clin Case Rep       Date:  2021-02-23

6.  Relentless Hypoxia in a Patient With Carcinoid Syndrome.

Authors:  Abdulrhman Alghamdi; Afnan A Malibari; Faisal Al-Husayni; Abdullah Jabri; Saad Albugami
Journal:  Cureus       Date:  2021-12-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.